(Q44225711)

1 December 2017

title

Plasma homocysteine levels and late outcome after coronary angioplasty (English)

1 reference

1 December 2017

1 reference

Guido Schnyder

1

1 reference

1 December 2017

Yvonne Flammer

2

1 reference

1 December 2017

Marco Roffi

3

1 reference

1 December 2017

Riccardo Pin

4

1 reference

1 December 2017

Otto Martin Hess

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of the American College of Cardiology

1 December 2017

published in

1 reference

1 December 2017

volume

40

1 reference

1 December 2017

issue

10

1 reference

1 December 2017

page(s)

1769-1776

1 reference

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocysteine, B vitamins, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Association of plasma homocysteine with the number of major coronary arteries severely narrowed

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Diet-induced hyperhomocysteinemia exacerbates neointima formation in rat carotid arteries after balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Increasing levels of dietary homocystine with carotid endarterectomy produced proportionate increases in plasma homocysteine and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Relation of a common methylenetetrahydrofolate reductase mutation and plasma homocysteine with intimal hyperplasia after coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Relation of homocysteine, vitamin B(12), and folate to coronary in-stent restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocysteine and cardiovascular disease: cause or effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

Decreased rate of coronary restenosis after lowering of plasma homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902481-6

7 January 2021

10.1016/S0735-1097(02)02481-6

Identifiers

DOI

1 reference

1 December 2017

1 reference